Avantor, Inc. (NYSE:AVTR) is Clarkston Capital Partners LLC's 10th Largest Position

Clarkston Capital Partners LLC increased its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 43.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,145,825 shares of the company's stock after purchasing an additional 2,473,395 shares during the quarter. Avantor makes up 3.3% of Clarkston Capital Partners LLC's portfolio, making the stock its 10th biggest holding. Clarkston Capital Partners LLC owned approximately 1.20% of Avantor worth $171,633,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AVTR. MassMutual Private Wealth & Trust FSB lifted its stake in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after purchasing an additional 625 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after buying an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its position in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares in the last quarter. UMB Bank n.a. boosted its stake in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after buying an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC purchased a new position in Avantor during the 4th quarter valued at approximately $65,000. Institutional investors own 95.08% of the company's stock.

Remove Ads

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now directly owns 40,604 shares of the company's stock, valued at $711,788.12. This trade represents a 10.78 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on AVTR shares. Barclays cut their target price on shares of Avantor from $23.00 to $18.00 and set an "overweight" rating for the company in a report on Thursday. Citigroup reduced their price target on Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Tuesday, March 4th. Morgan Stanley reduced their price target on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Royal Bank of Canada reduced their target price on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research report on Monday, February 10th. Finally, Wells Fargo & Company reduced their price objective on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Avantor currently has an average rating of "Moderate Buy" and a consensus target price of $25.08.

Avantor Stock Performance

AVTR traded up $0.21 during trading on Friday, reaching $14.91. 5,730,576 shares of the company's stock were exchanged, compared to its average volume of 6,781,709. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor, Inc. has a 1 year low of $13.80 and a 1 year high of $28.00. The company's fifty day simple moving average is $16.93 and its 200-day simple moving average is $20.55. The stock has a market capitalization of $10.16 billion, a P/E ratio of 14.37, a price-to-earnings-growth ratio of 1.55 and a beta of 1.24.

Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the business earned $0.22 EPS. As a group, research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.